HOME >> BIOLOGY >> NEWS
USDA and DOE to coordinate research of plant and microbial genomics

The U.S. Departments of Agriculture and Energy announced Monday they will share resources and coordinate the study of plant and microbial genomics, and the Department of Energy will tackle the sequencing of the soybean genome as the first project resulting from the agreement.

"This agreement demonstrates a joint commitment to support high-quality genomics research and integrated projects to meet the nation's agriculture and energy challenges," said Dr. Colien Hefferan, administrator of USDA's Cooperative State Research, Extension and Economics Service (CSREES), who signed the agreement for USDA.

"Both agencies will leverage their expertise and synergize activities involving agricultural- and energy-related plants and microbes," said Dr. Ari Patrinos, Department of Energy Associate Director of Science for Biological and Environmental Research. "We will enhance coordination of proposed sequencing projects through the Biological and Environmental Research Microbial Sequencing Program or the Joint Genome Institute's Community Sequencing Program."

USDA and DOE will establish a framework to cooperate and coordinate agency-relevant plant and microbial genome sequencing and bioinformatics that can serve the needs of the broader scientific community and solve problems that are important to each agency's mission. This agreement could help speed the deployment of emerging technologies, such as improved methods of gene identification and sequence assembly.

The DOE Joint Genome Institute (DOE JGI) will sequence the genome (decode the DNA) of the soybean, Glycine max, the world's most valuable legume crop. Soybean is of particular interest to DOE because it is the principal source of biodiesel, a renewable, alternative fuel. Biodiesel has the highest energy content of any alternative fuel and is significantly more environmentally friendly than comparable petroleum-based fuels, since it degrades rapidly in the environment. It also burns more
'"/>

Contact: Jeff Sherwood
jeff.sherwood@hq.doe.gov
202-586-5806
DOE/US Department of Energy
17-Jan-2006


Page: 1 2

Related biology news :

1. CRESIB coordinates an international consortium to fight malaria caused by Plasmodium vivax
2. The social life of honeybees coordinated by a single gene
3. Two national diabetes-related initiatives coordinated by MCG bioinformatics expert
4. NYU biologists identify gene that coordinates two cellular processes
5. Smithsonian to coordinate planning for Panamas Coiba National Park/World Heritage Site
6. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
7. Saudi Arabias KAUST names WHOI first research partner
8. Multinational research: protecting ecology means understanding people, too
9. Newly created cancer stem cells could aid breast cancer research
10. Carnegie Mellons Peter Adams receives EPA research grant
11. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: USDA and DOE coordinate research plant and microbial genomics

(Date:7/21/2015)... , July 21, 2015 Today, ZTE ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a leading smartphone manufacturer in China ... FPC1 02 5 for Axon , ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)...  Unchained Labs just can,t get enough biologics ... Nano. Avid Nano designs, develops and manufactures highly ... Also today, Unchained Labs UNcaged the pUNk, ... protein sizing system. The pUNk is a high-performance ... size distribution, aggregation population and molecular weight. Its ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
(Date:7/28/2015)... ... ... VetStem Biopharma will be offering weekly private guided tours of our new ... The tour and course will be given every Wednesday at 6pm to local interested ... members are welcome to attend with their veterinarian as well. Participants will be able ...
(Date:7/28/2015)... 28, 2015 Tauriga Sciences, Inc. (OTCQB:  TAUG) ... company, today announced that its stockholders approved an increase ... of the Company from 1,000,000,000 to 2,500,000,000 at its ... at the Law Offices of Nixon Peabody LLP in ... there were 480,655,929 shares of common stock represented either ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... , July 28, 2015 CSL Behring ... Administration has accepted for review the company,s Biologics License ... single-chain (rVIII-SingleChain) for the treatment of hemophilia A. In ... Hemophilia A is a ... VIII; nearly all affected patients are male. People with ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
Cached News: